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NFkB1 is a suppressor of neutrophil-driven
hepatocellular carcinoma
C.L. Wilson1, D. Jurk2, N. Fullard1, P. Banks1, A. Page1, S. Luli1, A.M. Elsharkawy3, R.G. Gieling4,
J. Bagchi Chakraborty5, C. Fox1, C. Richardson6, K. Callaghan1, G.E. Blair7, N. Fox7, A. Lagnado2,
J.F. Passos2, A.J. Moore8, G.R. Smith1, D.G. Tiniakos1, J. Mann1, F. Oakley1,* & D.A. Mann1,*
Hepatocellular carcinoma (HCC) develops on the background of chronic hepatitis. Leukocytes
found within the HCC microenvironment are implicated as regulators of tumour growth.
We show that diethylnitrosamine (DEN)-induced murine HCC is attenuated by antibody-
mediated depletion of hepatic neutrophils, the latter stimulating hepatocellular ROS and
telomere DNA damage. We additionally report a previously unappreciated tumour suppressor
function for hepatocellular nfkb1 operating via p50:p50 dimers and the co-repressor HDAC1.
These anti-inﬂammatory proteins combine to transcriptionally repress hepatic expression of a
S100A8/9, CXCL1 and CXCL2 neutrophil chemokine network. Loss of nfkb1 promotes ageing-
associated chronic liver disease (CLD), characterized by steatosis, neutrophillia, ﬁbrosis,
hepatocyte telomere damage and HCC. Nfkb1S340A/S340Amice carrying a mutation designed
to selectively disrupt p50:p50:HDAC1 complexes are more susceptible to HCC; by contrast,
mice lacking S100A9 express reduced neutrophil chemokines and are protected from HCC.
Inhibiting neutrophil accumulation in CLD or targeting their tumour-promoting activities may
offer therapeutic opportunities in HCC.
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T
he mechanisms driving the progression of chronic
inﬂammatory liver diseases such as alcoholic steatohepa-
titis and non-alcoholic steatohepatitis (ASH and NASH) to
hepatocellular carcinoma (HCC) are poorly understood. The
majority of HCC develops on the background of cirrhosis1, which
is the end-stage result of ﬁbrogenesis, a process of excessive
wound repair. This has led to the concept that the ﬁbrotic
extracellular matrix and/or pro-ﬁbrogenic myoﬁbroblasts may be
stimulators of HCC2. However, the increasing awareness that
non-cirrhotic HCC represents a high proportion of liver cancers
argues for additional mechanisms inherent in the inﬂammatory
process. Inﬂammation underpins roughly 20% of all solid
tumours and experimental studies have provided mechanistic
links between inﬂammatory mediators such as interleukin (IL)-6
and carcinogenesis3. The histopathological changes associated
with chronic ASH and NASH include persistent tissue inﬁltration
by neutrophils and lymphocytes4. Appearance of neutrophils in
the hepatic parenchyma is normally a transient process triggered
by damage-induced expression of soluble and insoluble
neutrophil guidance cues and is subsequently terminated by
neutrophil death and/or clearance by Kupffer cells5,6. This
transitory response is important for resolution of inﬂammation
and for protecting epithelial cells from bystander damage
resulting from exposure to neutrophil-derived reactive oxygen
species (ROS) and proteases. Persistence of neutrophils in chronic
liver disease (CLD) is therefore a pathological feature; however, it
remains unclear as to how neutrophils contribute to disease
progression. Experimental work in rodent models argues against
a role for neutrophils in wound repair or ﬁbrogenesis7,8. As
neutrophils are present in human HCC and its surrounding tissue
(Supplementary Fig. 1a), we were interested to determine whether
they functionally contribute to tumour development. Here we
demonstrate a requirement of hepatic neutrophils for the
development of carcinogen-induced HCC and deﬁne a pro-
tumour mechanism in which neutrophils cause telomere DNA
damage in bystander hepatocytes. We additionally deﬁne a
tumour suppressor role for the nfkb1 gene, which through the
expression of anti-inﬂammatory p50:p50 nuclear factor-kB (NF-
kB) dimers is able to transcriptionally repress a neutrophil
chemokine network.
Results
Neutrophils are required for experimentally induced HCC.
Diethylnitrosamine (DEN) acts as a complete liver carcinogen
when administered to mice 15 days after birth9. However, a role
for inﬂammatory mechanisms in this model is demonstrated by
the requirement for NF-kB activation in myeloid cells and for the
production of IL-6 by Kupffer cells, for injury to progress to
HCC10,11. To begin to investigate a role for neutrophils in this
process, we examined hepatic neutrophils across a 5- to 40-week
time course of DEN-induced disease in male C57BL/6 mice
(Fig. 1a). Elevated numbers of hepatic neutrophils were evident
throughout the disease process and underwent a steady increase
until 40 weeks where they were accompanied by enlarged livers,
substantial tumour frequency (Fig. 1b), large tumours
(Supplementary Fig. 1b) and high numbers of PCNAþ
proliferating hepatocytes (PCNAþ ) (Fig. 1c). To determine
whether neutrophils contribute to DEN-induced HCC, mice were
treated between weeks 32 and 40 with an antibody speciﬁc for the
mouse neutrophil antigen Ly6G, known to effectively suppress
neutrophil recruitment to tissues12. We conﬁrmed that anti-Ly6G
suppressed DEN-induced hepatic neutrophil accumulation with
little effect on F4/80þ macrophages or CD3þ lymphocytes
(Supplementary Fig. 1c). Selective depletion of neutrophils was
associated with a 3.5-fold reduction in tumour burden at 40
weeks and a slight reduction in liver/body weight ratio (Fig. 1d).
Mice lacking nfkb1 (encoding the NF-kB p50 subunit) display
exaggerated neutrophil inﬂammatory responses to injury in
multiple organs, including the liver13–15. Early (5 weeks) and
persistent elevation of hepatic neutrophils was observed in
DEN-injured nfkb1 / mice (Fig. 1a). Furthermore, these
animals exhibited rapid progression to aggressive HCC
(Fig. 1b). Of note, Cyp2E1 expression (Supplementary Fig. 1d)
and levels of liver injury and apoptosis (Supplementary Table 1
and Supplementary Fig. 1e) were similar between the two
genotypes, ruling out the possibility that differences in DEN-
induced liver injury caused the increased tumour burden.
Dysplastic cells and small tumours were evident at 20 weeks
(Supplementary Fig. 2a) in nfkb1 / mice, and by 30 weeks
there was an average of 32 visible surface liver tumour foci
compared with just 3 for wild type (WT; Fig. 1b). By week 40,
an average of 73 and 12 surface growths were recorded for
nfkb1 / and WT, respectively. Accelerated disease in
nfkb1 / liver was conﬁrmed by increased cell proliferation
(Fig. 1c), elevated hepatic expression of cyclin D1 (Supplementary
Fig. 2b) and loss of phospho-p38a (Supplementary Fig. 2c), the
latter being a feature of advanced human HCCs16. C57BL/6 mice
have a characteristically low rate (o4%) for the development of
spontaneous liver cancer. We were therefore surprised to observe
spontaneous CLD, a nodular appearance of the liver surface,
emergence of dysplastic nodules, an increase in liver/body weight
ratio and tumour frequency at 20 months in nfkb1 / males
(Fig. 1e). Histological assessment of the livers revealed that
nfkb1 / mice develop a spectrum of features of CLD, including
steatohepatitis, similar to that in humans, lobular mixed
inﬂammation and hepatocyte ballooning occasionally with
Mallory–Denk inclusions or megamitochondria, sinusoidal
ﬁbrosis and bridging ﬁbrosis in 50% of the mice (Fig. 1e and
Supplementary Fig. 2d). In ﬁve out of ten mice, hepatocellular
adenomas and/or well-to-moderately differentiated HCC were
observed (Supplementary Fig. 2e,f) in non-cirrhotic liver. In two
cases, portal biliary lesions resembling biliary microhamartomas
with no evidence of epithelial dysplasia were noted
(Supplementary Fig. 2f). Conversely, old WT mice develop mild
steatosis and some focal inﬂammation (Supplementary Tables 2
and 3). The spontaneous hepatic lesions in aged nfkb1 / mice
were associated with highly elevated numbers of hepatic
neutrophils (Supplementary Fig. 2g). To determine a functional
contribution of neutrophils in the nfkb1 / background, DEN-
injured mice were treated with either the neutrophil-depleting
antibody anti-Ly6G or control IgG between weeks 22 and 30
(this being the period of progression from dysplasia to HCC).
Anti-Ly6G treatment effectively reduced numbers of hepatic
neutrophils, normalized the liver/body weight ratio
(Supplementary Fig. 2h and Fig 1f) and blunted tumour
development (Fig. 1f) without affecting macrophage or
T-lymphocyte recruitment (Supplementary Fig. 2h). Taken
together, these data implicate neutrophils as important
functional contributors to inﬂammation-driven HCC.
Accelerated HCC in the nfkb1 / mouse. Cancer models in
extra-hepatic organs have suggested pro-tumour functions for
neutrophils, and that inhibition of neutrophil recruitment
or activities may be therapeutic options in the context of
chronic inﬂammatory disease17–21. Interrogating the mechanisms
responsible for enhanced neutrophil inﬂammation and aggressive
HCC phenotype of the nfkb1 / mouse will therefore provide
valuable mechanistic insights. Initial investigations ruled out
intrinsic differences in neutrophil functions such as apoptosis or
production of ROS (Supplementary Fig. 3a,b). We therefore
reasoned that either nfkb1 / hepatocytes have a deﬁciency in
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Figure 1 | Neutrophils are required for experimentally induced HCC. (a) Graph shows average total number of hepatic neutrophils ( NIMP-R14 ) in
DEN-injured WTor nfkb1 / mice. Red line denotes basal neutrophil levels in normal WT liver. (b) Average tumour counts and liver/body weight ratio in
30- and 40-week DEN-injured WT and nfkb1 / mice. Representative pictures of livers from 40-week DEN-injured WT and nfkb1 / mice.
(c) Average total number of PCNAþ hepatocytes in DEN-injured WT and nfkb1 / mice. (d) Diagram showing the experimental plan to deplete
neutrophils (Ly6G antibody) in WTmice from week 32–40 after DEN injury. Average tumour counts, representative pictures of livers and average
liver/body weight ratio graph in 40-week DEN-injured WT mice treated with control IgG or Ly6G antibody (Ab) for 8 weeks. n¼ 10 (e) Representative
pictures of liver from 20 month (aged under normal conditions) WT and nfkb1 / mice. Representative photomicrographs of haematoxylin and
eosin (H&E)- and Sirius red/fast green-stained liver sections from 20-month nfkb1 / mice (upper panel) revealed steatohepatitis (fat, blue arrows;
inﬂammation, yellow arrows; ballooned hepatocytes with Mallory–Denk bodies, green arrows) and ﬁbrosis (black arrows). Focal dysplasia (yellow dotted
line) with focal inﬂammation (black arrow) and HCC in H&E-stained nfkb1 / aged livers (lower panel). Graphs show average liver/body weight ratio and
tumour frequency identiﬁed histologically using H&E sections from 20-month, aged WT and nfkb1 / mice. n¼ 7 WT and ten nfkb1 / mice.
(f) Diagram showing the neutrophil depletion experimental protocol in nfkb1 / mice from week 22–30 after DEN injury. Average tumour counts,
representative pictures of livers and graph showing average liver/body weight ratio from 30-week DEN-injured nfkb1 / mice treated with control IgG or
Ly6G for 8 weeks (n¼ 10). All data are means±s.e.m; scale bars, 200mm. For a and c, n¼6, 4, 6, 7, 15 and 9 (nfkb1 / ), and 4, 4, 4, 5, 11 and 14 (WT)
for the 5- to 40-week time points). Statistical signiﬁcance was determined using one-way analysis of variance with Tukey’s post-hoc test (a,c) or an
unpaired t-test (b,e), *Po0.05, **Po0.01 or ***Po0.001 compared with control.
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their control of neutrophil recruitment, or/and nfkb1 /
neutrophils have an enhanced ability to trafﬁc to the liver. To
test the former idea, WT neutrophils were labelled ex-vivo with
Cellvue NR185 tracker before transfer into the circulation of
DEN-injured WT and nfkb1 / mice (Fig. 2a). Mice were then
imaged 4-h post transfusion by in vivo imaging system (IVIS) for
hepatic accumulation of labelled neutrophils, which were
discovered to be more abundant in nfkb1 / compared with
WT liver (Fig. 2b). This difference was also observed ex-vivo in
isolated organs (Fig. 2c) and, of note, labelled neutrophils
were restricted to the liver and the spleen. Carrying out the
reverse experiment, labelled WT or nfkb1 / neutrophils
were transferred into DEN-injured WT animals and hepatic
accumulation determined by IVIS. No differences were observed
between the genotypes, suggesting that the absence of nfkb1 /
within the neutrophil does not have an intrinsic effect on its
migratory ability (Supplementary Fig. 3c). To conﬁrm these data,
we produced chimeric mice in which either nfkb1 / bone
marrow was reconstituted into an irradiated WT background
(nfkb1 /BM4WT) or WT bone marrow was reconstituted in
the nfkb1 / background (WTBM4nfkb1 / ). In response to
acute DEN injury, neutrophils were recruited to the liver in both
backgrounds, but of note higher numbers of hepatic neutrophils
were present in WTBM4nfkb1 / mice (Supplementary
WT
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Figure 2 | Dysregulation of hepatic chemokine expression and accelerated HCC in the nfkb1 / mouse. (a) Diagram of the experimental plan using
whole-body imaging to track WT neutrophils to the liver of acute DEN-injured WT or nfkb1 / mice. (b) Representative IVIS pictures of mice given
NIR815-labelled WT neutrophils intravenously, showing neutrophils tracking to livers of acute DEN-injured WT or nfkb1 / mice. Graph shows average
radians from IVIS-imaged WT or nfkb1 / mice. (c) Representative ex vivo images of the liver (left), kidney (middle) and the spleen (right), and graph
showing average radians fromWTor nfkb1 / livers imaged ex vivo. n¼ 3 (d) Hepatic CXCL1, CXCL2, S100A9 and tumour necrosis factor-a (TNFa) mRNA
levels expressed as relative level of transcription difference (RLTD) compared with WT 48h post acute DEN in WT and nfkb1 / mice, n¼6. (e) Graph
shows RLTD of S100A9 in bone marrow macrophages (BMM) compared with hepatocytes isolated from WT and nfkb1 / mice, n¼ 3. (f) Hepatocyte
CXCL1 and CXCL2 mRNA levels expressed as RLTD in nfkb1 / mice compared with WT, n¼ 3. (g) Graph shows average total number of NIMP-R14 cells
in liver sections from WTor nfkb1 / mice after acute DEN injury-treated±IgG or CXCL1 and two neutralizing antibody, n¼ 5. (h) Average tumour counts,
representative pictures of livers and graph showing average liver/body weight ratio from 40-week DEN-injured WT and s100a9 / mice, n¼ 19. Hepatic
CXCL1 and CXCL2 mRNA levels expressed as RLTD in 40-week, chronic, DEN-injured WT and s100a9 /mice, n¼6. Data are means±s.e.m. Statistical
signiﬁcance was determined using an unpaired t-test, *Po0.05, **Po0.01 or ***Po0.001 compared with control.
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Fig. 3d). Of note, both the nfkb1 /BM4WT and
WTBM4nfkb1 / animals were considered too sick for use
in longer-term studies that would have conﬁrmed the hepatocyte-
speciﬁc actions of nfkb1 / in HCC; this phenotype may be
related to our recent report that nfkb1 / cells are highly
susceptible to radiation-induced senescence22. We conclude that
enhanced neutrophil recruitment in nfkb1 / mice most
probably reﬂects a defect in the hepatic regulation of neutrophil
trafﬁcking. We have recently reported that neutrophil migration
to the injured liver is critically dependent on a hepatic neutrophil
chemokine network comprised of calprotectin (S100A8/S100A9),
CXCL1 (Groa/KC) and CXCL2 (Grob/MIP2), and as the
expression of these proteins is under the transcriptional control
of NF-kB, it was relevant to determine their expression in
nfkb1 / liver7. CXCL2, S100A9 and tumour necrosis factor-a
were all signiﬁcantly overexpressed in DEN-injured nfkb1 /
liver (Fig. 2d and Supplementary Table 4). Modest increases for
CXCL1, S100A8 and IL-6 were also observed but failed to reach
statistical signiﬁcance (Fig. 2d and Supplementary Fig. 4a).
CXCL1, CXCL2, S100A9, IL-6 and tumour necrosis factor-a were
also highly upregulated in the diseased livers of 3-, 9-, 12-, 15-
and 20-month nfkb1 / males (Supplementary Fig. 4b and
Supplementary Table 4). At the protein level, S100A9
overexpression was located to mononuclear cells and
hepatocytes, and particularly strong S100A9 staining was found
within nfkb1 / tumour tissue (Supplementary Fig. 4c).
Analysis of S100A9 messenger RNA expression in isolated
macrophages demonstrated no difference between genotypes; by
contrast, S100A9 was not expressed in WT hepatocytes but was
detected in nfkb1 / hepatocytes (Fig. 2e). Expression of the
hepatocyte markers albumin and HNF4a, and macrophage
markers F4/80 and CD68 veriﬁed the purity of the cell
isolations (Supplementary Fig. 4d). CXCL1 and CXCL2
transcripts were highly overexpressed in cultured primary
nfkb1 / versus WT hepatocytes (Fig. 2f), this being
conﬁrmed by enzyme-linked immunosorbent assay (ELISA) for
CXCL2 (Supplementary Fig. 4e). Furthermore, number of
S100A9þ cells and hepatic expression of S100A9 mRNA were
higher in acute DEN-injured WTBM4nfkb1 / compared with
nfkb1 /BM4WT chimeric mice (Supplementary Fig. 3d).
These observations conﬁrm a previous report that calprotectin
expression is induced in damaged epithelia and HCC cells23. To
formally establish a requirement of CXCL1 and CXCL2 for
migration of neutrophils to DEN-injured liver, we neutralized the
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reveals that p50 mutants bind p50, except p50 S342A (human equivalent of mouse 340). Data are means±s.e.m. and representative of ﬁve mice per
group. Statistical signiﬁcance was determined using an unpaired t-test, **Po0.01 or ***Po0.001 compared with control.
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chemokines by an antibody approach in the context of acute
hepatic injury. Antibody-mediated combined inhibition of
CXCL1 and CXCL2 abrogated DEN-induced accumulation of
neutrophils in nfkb1 / mice (Fig. 2g). Unfortunately, this
approach was not practical for determining the role of CXCL1
and CXCL2 in HCC due to the need for longer-term
administration of high cost antibodies. However, calprotectin
regulates the hepatic expression of both CXCL1 and CXCL2.
s100a9 / mice express reduced levels of both chemokines upon
liver injury7 and transgenic expression of S100A8 and S100A9
stimulates overproduction of CXCL1 and mobilization of
neutrophils from the bone marrow24. Furthermore, neutrophil
recruitment is reduced in s100a9 / mice in acute DEN injury
(Supplementary Fig. 4f). We therefore determined the
susceptibility of s100a9 / to DEN-induced HCC and
discovered that these animals are protected compared with WT.
Reduced tumour burden in these animals was associated with
reduced hepatic expression of CXCL1 and CXCL2 (Fig. 2h). We
conclude that hepatocellular nfkb1 negatively regulates a
neutrophil chemokine network comprising calprotectin, CXCL1
and CXCL2. In support of this network having a pro-tumour
function, inhibition of CXCL1 and CXCL2 receptor CXCR2 is
sufﬁcient to suppress inﬂammation-driven skin and intestinal
cancers19. Furthermore, s100a9 / mice are protected against
cancers of inﬂammatory origin, including breast, pancreatic and
colitis-associated tumours25–27, although loss of S100A9 is
associated with susceptibility to experimental skin cancer28. To
further deﬁne the relative contributions of these chemokines to
the pathobiology of HCC, it will be necessary to generate
conditional genetic deletions enabling temporal control of their
expression targeted selectively to hepatocytes.
Disruption of p50 homodimers increases susceptibility to HCC.
Previous studies propose a model in which the anti-inﬂammatory
properties of nfkb1 are mediated by p50:p50 homodimers29–33.
Importantly, p50 lacks inherent transcriptional activity and
in homodimer form associates with co-repressors such as
HDAC1 or Bcl3, to actively repress inﬂammatory gene
transcription29,32,34,35. Of note, the nuclei of unstimulated cells
contains a signiﬁcant number of p50:p50 dimers that are assumed
to repress transcription36. Chromatin immunoprecipitation
(ChIP) assays conﬁrmed that p50 and HDAC1 are recruited to
the cxcl1, cxcl2 and s100a9 promoters (Fig. 3a,b). In contrast,
HDAC1 did not associate with these promoters in nfkb1 /
liver (Fig. 3b), supporting a model in which p50:p50 dimers
recruit repressive HDAC1 (or/and Bcl3) to suppress hepatic
expression of neutrophil chemokines (Fig. 3c). The mechanisms
that control NF-kB dimer assembly and, in particular, the choice
of heterodimers versus homodimers are very poorly understood,
yet will dictate the formation of anti-inﬂammatory
p50:p50:HDAC1 versus pro-inﬂammatory RelA:p50 complexes.
Sequence analysis of p50 protein reveals a region spanning
residues 325 to 354 (human p50) displaying high conservation
across evolutionarily distant species separated by 743 million
years (Fig. 3d). Aligning this region with equivalent sequences in
the mammalian NF-kB subunits revealed perfect conservation of
two serine residues, Ser337 and Ser342 (Fig. 3e). We noted in the
structure of mouse p50:p50 dimers bound to DNA that the
equivalent residue to human Ser342 (mouse Ser340) is located on
the opposing face from the dimerization interface where it might
exert conformational inﬂuences on dimer assembly (Fig. 3f).
Alanine mutations were introduced at Ser337, Ser342 and at other
evolutionary conserved residues (Thr145, Ser210 and Ser315) in
the context of human FLAG-p50. WT and mutant Flag-p50
proteins were co-expressed together with HA-p50 or EGFP-RelA,
to determine their relative abilities to assemble homodimers or
heterodimers, respectively. Pull-down assays demonstrated that
all mutant p50 constructs interacted with RelA to a similar degree
as WT-p50. Of note, the Ala342 mutant protein was consistently
expressed at reduced levels compared with WT-p50 and other
mutants (Fig. 3g). Homodimer interactions were similar between
WT-p50 and the 145, 210, 315 and 337 alanine mutants (Fig. 3h).
In contrast, the Ala342 mutant disabled p50:p50 assembly
(Fig. 3h). These mutagenesis experiments therefore reveal the
Ser342 residue to be a speciﬁc and critical determinant of p50
homodimer assembly. In further experiments, FLAG-Supershift
EMSA experiments conﬁrmed that FLAG-p50-Ala342 fails to
bind to kB motifs as would be expected, as p50 monomers are
unable to bind DNA (Supplementary Fig. 5a). The effects of the
mutation on chemokine gene expression were examined by
adenoviral overexpression of WT and mutant p50 proteins in
mouse hepatocytes (Supplementary Fig. 5b). As anticipated,
elevated levels of WT-p50 suppressed expression of CXCL1, but
this effect was not observed in cells expressing the mutant
homodimerization-defective p50 (Supplementary Fig. 5c). This
result conﬁrms that p50:p50 dimers are repressors of neutrophil
chemokine expression.
We next generated a genetically modiﬁed mouse carrying a
single alanine (Ala) mutation at Ser340 (Supplementary Fig. 6).
Homozygote nfkb1S340A/S340A mice were viable and developed to
adulthood without obvious defects or gross pathologies. Mutant
p105S340A and p50S340A proteins were expressed in all major
organs but at reduced levels relative to WT (Supplementary
Fig. 7a), although transcript levels were similar between WT
and nfkb1S340A/S340A liver tissues, indicating that loss of the
serine residue may reduce p105/p50 translation or stability
(Supplementary Fig. 7b). Of note, we did not detect signiﬁcantly
altered expression of other NF-kB subunits. Furthermore,
although total tissue levels of p50S340A were reduced, p50 and
RelA DNA binding were induced to a similar degree by DEN
injury at kB target sequences when comparing WT and
nfkb1S340A/S340A (Supplementary Fig. 7c). To assess the impact
of the mutation on neutrophil recruitment, adult nfkb1S340A/S340A
mice were injured acutely with DEN. Highly augmented acute
neutrophil inﬂammation was observed in the nfkb1S340A/S340A
background relative to WT controls (Fig. 4a). Furthermore,
hepatic CXCL1, CXCL2 and S100A9 were overexpressed when
compared with WT (Fig. 4b and Supplementary Fig. 7d).
To determine the susceptibility of nfkb1S340A/S340A mice to
DEN-induced HCC, a 40-week disease model was carried out
alongside WT controls. nfkb1S340A/S340A males developed sig-
niﬁcantly more tumours than WT (Fig. 4c). This accelerated
disease phenotype was conﬁrmed by increased liver weight,
elevated numbers of PCNAþ proliferating hepatocytes
(Fig. 4c,d) and substantially higher numbers of hepatic neutro-
phils (Fig. 4e). We have therefore identiﬁed a single amino acid
(Ser342 human or Ser340 mouse) that on mutation enhances
injury-induced expression of neutrophil chemokines and
increases susceptibility to HCC.
Neutrophils promote hepatocellular telomere damage. A
remaining question was the nature of the neutrophil-mediated
pro-tumour mechanism that is opposed by hepatocellular nfkb1.
This is likely to be multifactorial given the vast array of cytotoxic
molecules, inﬂammatory mediators and mitogenic factors
released by neutrophils37. However, when examining human
HCC tissue we were intrigued by the juxtaposition of neutrophil-
rich inﬂammatory foci with hepatocytes positive for
8-hydroxyguanosine, the latter being a biomarker for oxidative
DNA damage (Fig. 5a). In addition, immuno-ﬂuorescent in situ
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hybridization (FISH) using antibody against DNA damage
marker gH2A.X and FISH for the telomere-speciﬁc (C3TA2)3
PNA probe revealed the presence of tight clusters of hepatocytes
with telomere-associated DNA damage in human alcoholic liver
disease (Fig. 5b and Supplementary Fig. 8a). By contrast, we
detected negligible telomere-associated foci (TAFþ ) hepatocytes
in normal human liver (Fig. 5b). DNA damage in telomeres is
slow to repair38,39 and these lesions contribute to loss of telomere
integrity, chromosome instability and cancer40,41. This latter
concept was examined experimentally in the context of HCC by
Begus-Nahrmann et al.42 who reported that transient telomere
dysfunction in the liver is sufﬁcient alone to promote
chromosome instability and hepatocarcinogenesis. We therefore
employed immuno-FISH to examine telomere DNA damage in
DEN-injured mouse livers. A higher percentage of TAFþ
hepatocytes were found at 30 weeks in nfkb1 / livers
compared with WT (Fig. 5c). Comparison of TAF between WT
and nfkb1 / livers at early time points revealed no differences
in numbers of TAFþ hepatocytes at 5 weeks post-DEN injury
(Supplementary Fig. 8b); however, elevated numbers of TAFþ
cells were detected in nfkb1 / livers before tumour growth at
15 and 20 weeks post DEN (Supplementary Fig. 8c).
Furthermore, higher numbers of TAFþ cells were found in the
livers of 3-month-old nfkb1 / mice compared with age-
matched WT mice, again indicating TAFs precede the
development of HCC (Supplementary Fig. 8d). Notably, in vivo
treatment of DEN-injured nfkb1 / mice with anti-Ly6G
resulted in a signiﬁcant reduction in TAFþ hepatocytes
(Fig. 5d) coincident with reduced tumour burden (Fig. 1f).
From these data we conclude that the aggressive inﬂammatory
reaction that develops between 5 and 15 weeks post DEN in
nfkb1 / liver is accompanied by enhanced levels of
hepatocellular telomere DNA damage, and that the neutrophilic
component of the inﬂammatory reaction is the cellular mediator
of these telomere lesions.
Neutrophils induce oxidative DNA damage in bystander cells
by intercellular transfer of ROS43. Intracellular ROS causes lipid
peroxidation and generation of trans-4-hydroxy-2-nonenol
(4HNE), which following conversion to 2,3-epoxy-4HNE reacts
with deoxyadenosine and deoxycytidine resulting in DNA
lesions44. 4HNE-positive hepatocytes were consistently found in
greater numbers in nfkb1 / livers compared with WT across
the 5- to 40-week DEN time course (Fig. 6a). This correlated at
most time points with higher levels of hepatocellular DNA
damage (gH2A.Xþ cells) (Fig. 6b). In vitro experiments were
designed to test our hypothesis that neutrophils induce bystander
ROS and DNA damage in hepatocytes. Primary hepatocytes were
co-cultured either in direct contact with neutrophils or were
exposed to neutrophil-derived diffusible factors by means of
transwell culture (Fig. 6c). Measurement of intracellular ROS
within co-cultured hepatocytes revealed that either direct or
indirect contact with neutrophils was sufﬁcient to elevate
hepatocellular ROS (Fig. 6d). Representative 4,6-diamidino-2-
phenylindole (DAPI)/53BP1-stained hepatocytes from these
co-cultures were used to quantify the percentage of hepatocytes
with DNA damage foci. 53BP1þ foci were more abundant in
co-cultures compared with monoculture controls (Fig. 6e and
Supplementary Fig. 9a). As in vivo conﬁrmation that neutrophils
are contributors to ROS-induced lipid peroxidation, treatment
with anti-Ly6G reduced the numbers of 4HNEþ hepatocytes
(Supplementary Fig. 9b). Further in vivo support for ROS as a
mediator of neutrophil-stimulated HCC was demonstrated by
therapeutic application of the dietary anti-oxidant butylated
hydroxyanisole (BHA), which protected against progression of
the aggressive DEN-induced HCC disease in the nfkb1 /
background (Fig. 6f). This protective effect of BHA was
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accompanied by reduced 4HNEþ (Fig. 6g) and gH2A.X-stained
(Fig. 6h) hepatocytes, providing a clear in vivo correlation
between neutrophil-derived ROS, oxidative DNA damage and
development of HCC.
Discussion
Neutrophil inﬁltration is associated with poor prognosis in a
variety of human cancers including colorectal carcinoma, head
and neck squamous carcinoma, bronchioloalveolar carcinoma
and HCC45. Here we have described how inﬂammatory signals
released from hepatocytes in the damaged liver orchestrate the
recruitment of circulatory neutrophils into the hepatic
parenchyma where they stimulate genotoxic damage in
bystander hepatocytes inclusive of telomere lesions that are
sufﬁcient to stimulate HCC40,42. This contrasts with an apparent
lack of contribution of neutrophils to regenerative or ﬁbrogenic
responses in the injured liver7,8 and indicates that the presence of
neutrophils in human ASH and NASH liver may be a risk factor
for progression to HCC, making these cells potential therapeutic
targets. Signiﬁcant challenges will be to conﬁrm the role of
neutrophils in human CLD and to then translate this knowledge
to strategies for manipulating neutrophils in the diseased liver.
For the latter, opportunities include in-development small
molecular inhibitors that block activities of the IL-8 family
chemokines or their neutrophil receptor CXCR2 (ref. 46).
Alternatively, the tumour suppressor activities of the NFkB1
gene may be exploitable. We have presented data in support of an
anti-tumour mechanism for NFkB1 via p50:p50-mediated
transcriptional repression of neutrophil-recruiting chemokines.
Single planeMax projection
Merge
i
ii
i
ii
FISH γH2A.X
MergeFISH γH2A.X
Pe
rc
e
n
t T
AF
 +
 c
el
ls
Fl
uo
re
sc
en
ce
in
te
ns
ity
 (A
U)
80
70
60
50
40
30
20
10
0
**
Normal
liver
ALD
Telomeres
γH2A.X
Telomeres
γH2A.X
Pe
rc
e
n
t T
AF
 +
 c
el
ls
80
70
60
50
40
30
20
10
0
Pe
rc
e
n
t T
AF
 +
 c
el
ls
***
IgG
nfkb1–/–
Ly6G
80
70
60
50
40
30
20
10
0
0.0 0.4 0.8 1.2
Distance (μM)Distance (μM)
Fl
uo
re
sc
en
ce
in
te
ns
ity
 (A
U)
n
fk
b1
–
/–
 
30
 w
k 
DE
N
AL
D
1.60.0 0.4 0.8 1.2 1.6
0
50
100
200
150
250
0
20
40
60
80
100
120
140
0.0 0.4 0.8 1.20.0 0.4 0.8 1.2
Distance (μM)Distance (μM)
0
50
100
200
150
250
0
50
100
200
150
250
300 **
WT nfkb1–/–
HCC
8-
O
HG
 s
ta
in
Cirrhotic liver
i ii
i ii
Figure 5 | Neutrophils promote hepatocellular telomere DNA damage. (a) Representative photomicrographs at  200 magniﬁcation of 8-OHG staining
in liver sections from cirrhotic livers and HCC, black arrows denote brown positively stained areas of damage in hepatocytes and red arrows show
inﬂammatory cells. Scale bars, 100 mm . (b) Representative deconvolved maximum intensity projections of telomere FISH and phospho-H2A.X (gH2A.X)
staining in alcoholic liver disease (ALD) liver sections (n¼ 2 normal human liver and n¼4 ALD). Graph shows per cent TAFþ hepatocytes in ALD liver
compared with normal control liver. (b,c) Graphs (i–ii) show the ﬂuorescence intensity and co-localization of telomere FISH and gH2A.X staining of the
corresponding single plane images. Scale bars, 3 mm . (c) Representative immuno-FISH images (deconvolved maximum intensity projections) from
30-week DEN-injured nfkb1 / livers, n¼ 5. Graph per cent TAF TAFþ hepatocytes in WT versus nfkb1 / 30-week DEN livers. (d) Graph shows
per cent TAFþ hepatocytes in 30-week DEN-injured nfkb1 / mice treated with control IgG or Ly6G antibody for 8 weeks, n¼ 10. All data are
means±s.e.m. TAF analysis, a minimum of 50 cells per liver counted for human sections and a minimum of 80 cells counted per mouse section).
Statistical signiﬁcance was determined using an unpaired t-test, **Po0.01 or ***Po0.001 compared with control.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7818
8 NATURE COMMUNICATIONS | 6:6818 | DOI: 10.1038/ncomms7818 | www.nature.com/naturecommunications 
From our observations, we predict that enhancing the anti-
inﬂammatory properties of p50:p50 and its co-repressor HDAC1
in hepatocytes would have suppressive effects on the hepatic
expression of multiple neutrophil chemokines, thereby limiting
hepatic neutrophil accumulation and reducing the incidence of
genotoxic and telomeric damage in bystander hepatocytes.
Possible approaches would be to exploit the ability of co-factor
Bcl3 to enhance stability of p50:p50 dimers at promoters34 or to
manipulate the assembly of p50 subunits into homodimers over
heterodimers. Towards the latter aim, we have begun to
investigate structural features of p50 that dictate the choice of
dimer partner and have identiﬁed human S342/mouse S340
as non-essential for heterodimer assembly but essential for
homodimers. A mouse carrying a mutation at S340 displayed
similar disease phenotypes to the nfkb1 / mouse including
increased susceptibility to HCC. We have therefore demonstrated
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that p50 contains discrete structural components that can be
manipulated to modify its selection of dimer partner and which
have an impact on inﬂammation-associated cancer. Therefore,
more detailed structure–function studies on p50 are warranted
with the aim of discovering how to experimentally promote the
assembly and stabilization of anti-inﬂammatory p50:p50 dimers.
A caveat with the concept of inhibiting hepatic neutrophil
recruitment in CLD is the potential dual role for neutrophils in
cancer and the risk of removing neutrophil-mediated cytotoxic
activities directed against tumour cells47. Disarming the harmful
bystander effects of neutrophils on hepatocytes while retaining
their anti-tumorigenic activities may be an optimal approach.
Our discovery that neutrophils induce ROS-mediated telomere
damage on bystander hepatocytes is therefore signiﬁcant given
the associations in the literature between telomere lesions,
telomerase reactivation and cancer42. Telomere DNA damage
foci were detected in vivo in diseased livers and found to be
exacerbated in nfkb1 / mice, but were ameliorated in animals
treated with anti-Ly6G. In vitro co-culture experiments conﬁrmed
the ability of neutrophils to induce telomere DNA lesions in
hepatocytes and indicated a diffusible mediator is responsible for
this bystander damage. In this regard, long-lived neutrophil-
derived ROS species (for example, HOCl and N-chloramines)
and/or proteolytic enzymes are worthy of future consideration
and, in particular, as they are also naturally occurring DNA repair
inhibitors48.
It is pertinent to consider the relevance of our ﬁndings for
inﬂammation-driven cancer in humans. The degree to which
currently available rodent models of liver disease recapitulate the
pathologies underpinning the development of HCC in humans is
questionable. It is worth noting the absence of the ageing process
in these models, which is intimately linked with CLD and HCC in
humans. Ageing is associated with a physiological increase in
hepatic lipid accumulation, elevated systemic expression of
inﬂammatory mediators, loss of replicative potential for hepato-
cytes and a substantially increased risk for the development
of ﬁbrosis and HCC49. We have recently reported that the
nfkb1 / mouse has a reduced lifespan that is associated with
increased levels of cellular senescence in regenerative organs
including the liver, which can be ameliorated by treatment with
the anti-inﬂammatory drug ibuprofen22. Here we now document
in these mice the spontaneous age-dependent development of
numerous lesions that are reminiscent of those found in age-
associated human liver disease including steatosis, hepatitis,
ﬁbrosis, ductular proliferation, dysplasia and HCC. Further
detailed investigations of the interplay between mechanisms of
accelerated liver ageing and cancer in the nfkb1 / background
may be highly illuminating. Finally, although there is no obvious
human model for loss of p50 homodimers, there are common
polymorphisms in the human NFKB1 gene that have been
genetically linked with inﬂammatory disease. In particular, the
–94 del/ins (rs28362491)-promoted polymorphism, which is
predicted to result in reduced expression of p50, is associated
with increased risk for HCC and for other cancers including
breast, prostate, gastric, colorectal and oral50–53. However, as yet
there are no investigative studies in the literature examining the
impact of the –94 del/ins polymorphism on dimer assembly and
occupancy at NF-kB-regulated genes.
Methods
Mice and models of liver injury. All experiments on male C57BL/6 (WT),
nfkb1 / , s100a9 / and nfkb1S340A/S340A mice were performed under approval
from the Newcastle Ethical Review Committee and a UK Home Ofﬁce licence.
s100a9 / mice were kindly provided by Professor Nancy Hogg (UK), nfkb1 /
mice were a gift from Professor J. Caamano (UK). nfkb1 / and s100a9 / mice
were bred in-house as homozygous lines and compared with in-house C57BL/6
mice. nfkb1S340A/S340A homozygous knock-in mice and WT controls were derived
from nfkb1S340A/WT heterozygous knock-in mice custom made at Taconic. Day 15
mice were given 30mg kg 1 N-Nitrosodiethylamine (DEN) in 0.9% saline by
intraperitoneal (i.p.) injection to induce liver cancer. Acute DEN, 8-week-old mice
were given 100mg kg 1 by i.p. injection to induce liver DNA damage. Either
power calculations or previous studies, which achieved statistical signiﬁcance, were
used to determine all group sizes.
Genotyping of nfkb1S340A/S340A mice. Genotyping was performed by PCR using
genomic DNA isolated from ear clips. Tissue sample was the digested tissue in a
buffer of 0.5% SDS, 20mM EDTA, 200mM NaCl, 40mM Tris pH8.0, with
50 mgml 1 proteinase K at 55 C overnight, followed by phenol/chloroform
extraction and DNA precipitation. The WT or nfkb1S340A/S340A alleles were
ampliﬁed using NeoDel forward 50-GTCTTCAAAACGCCAAAGTATAAGGAT
GTC-30 and NeoDel reverse 50-CCCCTCCTGGTGGAGGACCAC-30 speciﬁc
primers for 30 cycles; denaturation: 98 C, 10 s; annealing: 58 C, 15 s; extension:
68 C, 1min). Ampliﬁcation of a single product of 490 or 620 bp corresponds to
WT or 340þ /þ allele, respectively. Ampliﬁcation of both products corresponds to
a heterozygous (þ / ) genotype (Supplementary Fig. 6a–c).
Therapies. Mini-pumps (Alzet, model 2004) were implanted subcutaneously into
22-week DEN-injured (nfkb1 / ) or 32-week DEN-injured (WT) mice to deliver
28.5 mg per day of Ly6G (clone 1A8) neutrophil depleting antibody or Rat IgG2a
(clone 2A3) (BioXCell) for 8 weeks. nfkb1 / mice were fed BHA (0.7% w/w)
or normal chow 15 weeks post DEN for 15 weeks. CXCL1 and CXCL2 were
neutralized by administering i.p. 25 mg of anti-CXCL1 (AF-453-NA) and 25 mg of
anti-CXCL2 (AF-452-NA) or 50mg goat IgG (AB-108-C) 1 h before and 18 h post
acute DEN. At the end of the experiment, animals were culled, and the liver and
serum harvested for analysis.
In vivo imaging. WT neutrophils were labelled using the Cell Vue NIR815
ﬂuorescent kit (Li-Cor), according to manufacturers instructions, then 1 107 cells
were injected intravenously via the tail vein into 18 h acute DEN-injured WT or
nfkb1 / mice. The IVIS220 series imaging system (Ex max 786 nm; em max
814 nm ﬁlters) was used to longitudinally track neutrophil migration; after the ﬁnal
scan, animals were culled and the liver, kidney and the spleen were removed and
imaged ex vivo. Data were analysed using Living Image 4.2 software, regions
of interest were drawn and Average Radiant Efﬁciency (p s  1cm 2 sr 1)/
(mWcm 2) was calculated.
Neutrophil isolation. Brieﬂy, bone marrow was extracted from the femur and tibia
of WT, nfkb1 / and nfkb1S340A/S340A mice by ﬂushing with HBBS–Ca2þ
with 5% serum. Neutrophils were isolated by percoll gradient (62%) and purity
was established by Ly6G and CD11b (BD Biosciences) ﬂow cytometry (BD
FACScantoII). We used the 7AAD and Annexin V apoptosis detection kit
according to manufacturers instruction (BD Biosciences) and ﬂow cytometry to
measure neutrophil apoptosis.
Generation of bone marrow chimera. Eight- to 12-week-old WT and nfkb1 /
mice were used as donors and recipients. Bone marrow cells were isolated from
WT and nfkb1 / mice as described above. The bone marrow cell suspension was
washed, centrifuged at 400g for 5min, then re-suspended and counted. Recipient
mice underwent whole body irradiation (NDT 320KV 3.2KW irradiator) at 10Gy
and then received 107 bone marrow cells intravenously.
Hepatocyte isolation. Hepatocytes were isolated from the livers of WT,
nfkb1 / and nfkb1S340A/S340A mice by digestion with collagenase from
Clostridium histolyticum (Sigma), then ﬁltered through a 70-mm cell strainer. Cells
were collected by centrifugation (500 r.p.m. for 3min), washed three times in
Krebs–Ringer buffer (Sigma) and then re-suspended in Williams medium E with
10% serum (WME Gibco), and plated onto collagen-coated plates (type I collagen,
BD Biosciences). After 4 h, medium was removed and cells were cultured in fresh
10% or 0.5% Williams medium E.
Hepatocyte and neutrophil co-culture and ROS production. WT and nfkb1 /
hepatocytes were plated on collagen-coated transwell plates, then co-cultured with
WT or nfkb1 / neutrophils±a 3-mm transwell insert (Thincert Griener) at a 1:1
ratio for 18 h. Intracellular ROS of hepatocytes and isolated neutrophils was
measured following incubation with 10 mM diﬂuoroﬂuorescein diacetate (FITC
488 nm), 5 mM dihydroehidium (Rhodamine, 594 nm) or 5 mM Cell Rox Orange for
30min at 37 C. Median ﬂuorescence intensity was measured by ﬂow cytometry.
Up to 10,000 events were analysed on FACScan/FACS Canto II (BD, Oxford, UK)
using Flowjo software (FlowJo, Inc.).
Bone marrow macrophages. Bone marrow cells from the femurs of WT or
nfkb1 / mice were differentiated into macrophages (7 days with RPMI media
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supplementedwith 5% horse serum (Sigma-Aldrich) and 10% L929 supernatant
(refreshed on days 3 and 6)).
Cell culture. Cos-7 cells were cultured in DMEM supplemented with 100Uml 1
penicillin, 100 mgml 1 streptomycin, 2mM L-glutamine and 16% fetal bovine
serum at 37 C at an atmosphere of 5% CO2.
Adenoviral expression of WT and S340A p50. Hepatocytes were transduced
with one green ﬂuorescent forming unit per cell of control adenovirus or adeno-
virus expressing either WT murine p50 or S340A p50 for 24 h. Adenovirus was
kindly provided by Professor G Eric Blair (UK).
Human tissue. HCC and alcoholic liver disease liver samples for histology were
collected under full ethical approval with patient consent (REC references
10/H0906/41).
ChIP assay. Cross-linked chromatin was prepared from acute DEN-injured WT,
nfkb1 / and nfkb1S340A/S340A mouse livers, using the protocol outlined in the
Upstate Biotechnology Immuno-precipitation ChIP assay kit. ChIP was performed
using 25 mg of cross-linked chromatin per reaction and 5 mg of antibody to HDAC1
(05-100 Millipore), p50 (ab7971 Abcam) or IgG control (Abcam) for immuno-
precipitation. Mouse S100A9, CXCL1 and two promoters were ampliﬁed by
quantitative reverse transcriptase–PCR using speciﬁc primers (Supplementary
Methods Table 1).
Electromobility shift assay. Cos-7 cells were co-transfected with 1 mg Flag-tagged
WT-p50 or mutant-p50 using the effectene kit (Qiagen). After 48 h, cells were lysed
with Dignam A buffer and incubated on ice for 15min with vortexing, then
centrifuged at 900g at 4 C for 30 s. The cell pellet was re-suspended in Dignam C
buffer and incubated on ice for 15min. After centrifugation at 900g (4 C) for 5min
nuclear extracts were removed and stored at  80 C. p50 For EMSA, brieﬂy
8–10 mg of nuclear extract was incubated with poly dIdC and 32P-labelled NFkB
Oligonucleotide (Promega) for 20min at 4 C. For supershift assays, reactions were
incubated in the presence of 2 mg of anti-ﬂag or anti-myc as a negative control
(Sigma) for 16 h at 4 C. EMSA and supershift reaction mixtures were resolved by
electrophoresis on an 8% non-denaturing polyacrylamide gel (37:5:1).
Enzyme-linked immunosorbent assay. WT and nfkb1 / hepatocytes were
cultured overnight before protein extraction from the pelleted cells. Twenty
micrograms of protein was used for CXCL2/MIP2 ELISA. The ELISA was per-
formed according to the manufacturer’s instructions (R&D Quantikine ELISA kit).
Histological stains. Formalin ﬁxed, parafﬁn-embedded liver sections were stained
with haematoxylin and eosin and 0.1% Sirius Red Picric solution following
standard procedures. Diastase PAS, Reticulin and Sirius red/fast green, keratin 19
and glutamine synthetase were immunostained at the Department of Cellular
Pathology, Royal Victoria Hospital, Newcastle Upon Tyne.
Immunohistochemistry. Staining was performed on formalin-ﬁxed, parafﬁn-
embedded liver sections. Endogenous peroxidase activity was blocked with
hydrogen peroxide and antigen retrieval was achieved using proteinase K
(20 mgml 1) for detection of F480 1:100 (ab6640 Abcam), 0.01% pronase for
neutrophil elastase 1:200 (ab21595 Abcam) and NIMP-R14 1:200 (ab2557 Abcam),
and antigen unmasking solution for active caspase-3 1:200 (9664 Cell Signaling),
S100A9 1:100 (ab73987 Abcam), 4HNE 1:50 (MHN-020P JalCA), aSMA 1:1000
(F3777 Sigma) and Collagen IV 1:100 (Abcam). EDTA (1mM) for gH2A.X 1:100
(9718 Cell Signaling) and trypsin for PCNA 1:250 (ab2426 Abcam). Tissue was
blocked using an Avidin/Biotin Blocking Kit (Vector Laboratories) followed by
20% swine serum in PBS and then incubated with primary antibodies overnight
at 4 C. The next day, slides were washed and incubated with biotinylated swine
anti-rabbit 1:200 (eo353 Dako), biotinylated goat anti-ﬂuorescein 1:300 (BA-0601
Vector) or goat anti-rat 1:200 (STAR80B Serotec), followed by Vectastain Elite
ABC Reagent. Antigens were visualized using DAB peroxidase substrate kit and
counterstained with Mayer’s haematoxylin. For 4HNE, ampliﬁcation was achieved
using the mouse on mouse kit (Vector) Immuno-stained cells were manually
counted and expressed as the mean number of positive cells in 15 high power
( 20) ﬁelds. Image analysis of a minimum of ten ﬁelds ( 10) was performed
using Leica Qwin for F4/80. All stained histological sections were blinded before
counting/analysis.
Histological assessment of liver disease and cancer. Histological examination
of aged WT and nfkb1 / liver sections was performed by a liver pathologist
(DGT) and immunostains were evaluated by two observers (DGT and FO).
Steatosis severity, the presence of steatohepatitis and extent of ﬁbrosis were
assessed according to Kleiner et al.54 Evaluation of hepatocellular dysplasia and
neoplasms was based according to established histological criteria55.
Telomere immuno-FISH. Formalin-ﬁxed parafﬁn-embedded liver sections were
dewaxed and hydrated, washed with water and then citric saline antigen retrieval
was performed. Slides were blocked with normal goat serum (1:60) in BSA/PBS and
incubated with rabbit g-H2A.X (1:250) at 4 C overnight. The next day, slides were
washed three times in PBS, incubated with secondary antibody for 30min, washed
three times in PBS and then incubated with Avidin DCS (1:500) for 20min. After
g-H2A.X immunoﬂuorescence, slides were washed three times in PBS, cross-linked
with 4% paraformaldehyde for 20min and dehydrated in graded ethanol. Sections
were denatured for 10min at 80 C in hybridization buffer (70% formamide
(Sigma), 25mMMgCl2, 0.1M Tris pH 7.2, 5% blocking reagent (Roche) containing
2.5 mgml 1 Cy-3-labelled telomere-speciﬁc (50-CCCTAA-30) peptide nuclei acid
probe (Panagene), followed by hybridization for 2 h at room temperature in the
dark. Slides were washed twice with 70% formamide in 2 SSC for 15min, fol-
lowed by 2 SSC and PBS washes for 10min. Next, sections were incubated with
DAPI, mounted and imaged. In-depth Z stacking was used (a minimum of 40
optical slices with  63 objective, Leica DM5500B) followed by Huygens (SVI)
deconvolution. Whole-image stacks were used to count TAFs.
Immunocytochemistry. Hepatocytes were cultured on sterile collagen-coated
coverslips, then ﬁxed in 2% paraformaldehyde for 10min and then blocked cells for
45min with 0.2% Fish skin Gelatine, 0.5% BSA and 0.5% Triton X-100 in PBS.
Slides were then incubated with the rabbit polyclonal anti-53BP1 4 mgml 1
(NB100-904 Novus Biologicals) overnight at 4 C. The next day, the cells were
washed and incubated with Alexa Fluor 594 secondary antibody (Invitrogen) for
60min before mounting with DAPI mountant (Vector).
RNA isolation and real-time PCR. Total RNA was isolated from mouse liver or
cultured cells using the Total RNA Puriﬁcation Kit (QIAGEN) and then treated
with DNAse and used as a template in ﬁrst-strand complementary DNA synthesis
using random primers (Promega). SYBR Green quantitative reverse transcriptase–
PCR was performed using the primers listed in (Supplementary Table 5).
Generation of p50 constructs. Flag-p50 and HA-p50 was sub-cloned into
pCDNA3 using HindIII and ApaI restriction enzyme digestion and used as a
template to generate the following Flag- and haemagglutinin (HA)-tagged p50
mutant constructs: p50 T145A mutant, p50 S210A mutant, p50 T315A mutant,
p50 S337A mutant and p50 S342A mutant by two-step site-directed mutagenesis.
A common Flag tag or HA tag forward primer was used with the respective mutant
reverse primer. A common reverse primer was used for the second PCR reaction.
Final PCR products were restriction enzyme digested with HindIII and ApaI,
separated on 1% agarose gel, excised, puriﬁed and sub-cloned them into pCDNA3.
The primer sequences used are listed in (Supplementary Table 6).
Co-transfection and immunoprecipitation. To assess p50:RelA interactions,
Cos-7 cells were co-transfected with 0.5 mg RelA-eGFP and 1 mg Flag-tagged
WT-p50 or mutant-p50. For p50:p50 interactions, Cos-7 cells were co-transfected
with 0.5 mg of Flag-tagged WT-p50 or mutant-p50, and 1 mg of HA-tagged WT-p50
construct. The Flag immunoprecipitation kit (Sigma) was used according to the
manufacturer’s instructions. At 36 h post transfection, cells were PBS washed and
then lysed into RIPA buffer (input control) or lysed with Flag lysis buffer (50mM
Tris HCl, pH 7.4, with 150mM NaCl, 1mM EDTA and 1% Triton X-100). Flag
beads were washed in wash buffer (50mM Tris HCl pH 7.4 with 150mM NaCl)
and then 1mg of cell lysate was added to the beads. Cell lysates and beads were
agitated overnight at 4 C and then centrifuged at 13,000 r.p.m. for 30 s. The
supernatant was removed and the remaining beads were washed 3 in wash
buffer. Protein was then eluted by adding 100ml of 3 Flag peptide and incubated
at 4 C for 30min with gentle agitation. The beads were centrifuged and the
supernatant removed. Thirty micrograms of input control and 50 ml of IP eluate
was loaded onto a 9% SDS–PAGE gel for western blotting.
Isolation of whole-tissue lysates. Tissue (B5mg) was lysed and homogenized
in 300 ml RIPA buffer supplemented with protease and phosphatase inhibitor
cocktails. Lysates were passed through a QIAshredder and then spun at 16,000g for
2min. Flow through was collected and sonicated for 10 s. Debris was pelleted by
centrifugation at 16,000g at 4 C for 15min and the supernatant was collected.
Protein concentration was measured using the detergent-compatible protein assay
kit purchased from Bio-Rad.
SDS–polyacrylamide gel electrophoresis. Total protein was fractionated by 9%
SDS–PAGE, transferred onto nitrocellulose and then blocked blots with Tris-
buffered saline and Tween 20 (0.1%) containing 5% BSA before incubation
overnight with primary antibodies (1:1,000) to S100A9 (ab73987 Abcam), PCNA
(ab2426 Abcam), Cyclin D1 (ab16663 Abcam), p105/p50 (ab7971 Abcam), RelA
(ab7970 Abcam), c-Rel (sc71 Santa Cruz), CyP2E1 (ab28146 Abcam) or GAPDH
(Abcam), total p38a (9218 Cell Signaling), P-p38a (9216 Cell Signaling), HA or
Flag-HRP conjugate (Sigma). Next day, membranes were washed in T-TBS and
then incubated with horseradish peroxidase-conjugated mouse anti-rabbit IgG.
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Blots were washed and antigen was detected using enhanced chemiluminescence
(Amersham Biosciences). Images have been cropped for presentation. Full-size
images are presented in Supplementary Fig. 10.
Model of p50 homodimer binding DNA. Molecular graphics images were
generated using PyMOL (DeLano Scientiﬁc) and solvent-accessible surface areas
calculated with Stride56.
Statistical analysis. Data are expressed as means±s.e.m. GraphPad Instat was
used to perform unpaired Students t-test or analysis of variance with a Tukey’s
post-hoc test and *Po0.05, **Po0.01 or ***Po0.001 was considered signiﬁcant.
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Corrigendum: NFkB1 is a suppressor of
neutrophil-driven hepatocellular carcinoma
C.L. Wilson, D. Jurk, N. Fullard, P. Banks, A. Page, S. Luli, A.M. Elsharkawy, R.G. Gieling, J. Bagchi Chakraborty,
C. Fox, C. Richardson, K. Callaghan, G.E. Blair, N. Fox, A. Lagnado, J.F. Passos, A.J. Moore, G.R. Smith,
D.G. Tiniakos, J. Mann, F. Oakley & D.A. Mann
Nature Communications 6:6818 doi: 10.1038/ncomms7818 (2015); Published 16 Apr 2015; Updated 21 Sep 2015
The diagram in Supplementary Fig. 6a illustrating the targeting strategy for the nfkb1S340A KI allele depicts an unrelated targeting
strategy. The correct version of the ﬁgure appears below.
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